Covered recipient · General Payments record
MOHAMMAD FAHAD SALAM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$991.37
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $854.68 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $289.19 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $278.25 | 2 |
| Amgen Inc. | $122.09 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $84.24 | 1 |
| Abbott Laboratories | $66.62 | 2 |
| Novo Nordisk AS | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $27.80 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125220126 | CMS |
| Abbott Laboratories | $38.82 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125220128 | CMS |
| ABIOMED | $29.31 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142282845 | CMS |
| ABIOMED | $112.74 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142282853 | CMS |
| ABIOMED | $147.14 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142282935 | CMS |
| Amgen Inc. | $122.09 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116081160 | CMS |
| Boston Scientific Corporation | $140.01 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092309236 | CMS |
| Boston Scientific Corporation | $138.24 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092309238 | CMS |
| Novo Nordisk Inc | $14.29 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097448605 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $84.24 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080667079 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.